TMDI
Income statement / Annual
Last year (2021), Titan Medical Inc.'s total revenue was $20.09 M,
an increase of 0.47% from the previous year.
In 2021, Titan Medical Inc.'s net income was -$14.86 M.
See Titan Medical Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
| Period Ended |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
| Operating Revenue |
$20.09 M |
$20.00 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$58,064.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$20.09 M
|
$20.00 M
|
-$58,064.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$37.96 M
|
$7.94 M
|
$51.42 M
|
$32.86 M
|
$12.90 M
|
$22.58 M
|
$38.21 M
|
$10.68 M
|
$5.35 M
|
$4.64 M
|
| General & Administrative Expenses |
$12.43 M
|
$7.49 M
|
$7.81 M
|
$6.80 M
|
$5.97 M
|
$4.93 M
|
$3.53 M
|
$3.50 M
|
$3.48 M
|
$3.08 M
|
| Selling & Marketing Expenses |
$0.00
|
$140,976.00
|
-$5.00
|
$2.00
|
$1.00
|
-$5.00
|
$1.00
|
-$4.00
|
-$114,219.60
|
$9,815.35
|
| Selling, General & Administrative Expenses |
$12.43 M
|
$7.63 M
|
$7.81 M
|
$6.80 M
|
$5.97 M
|
$4.93 M
|
$3.53 M
|
$3.50 M
|
$3.37 M
|
$3.09 M
|
| Other Expenses |
$699,000.00
|
$0.00
|
$32,551.00
|
$29,040.00
|
$17,355.00
|
$24,635.00
|
$32,390.00
|
$23,660.00
|
$118,749.00
|
$154,997.00
|
| Operating Expenses |
$51.08 M
|
$15.57 M
|
$59.27 M
|
$39.69 M
|
$18.88 M
|
$27.53 M
|
$41.77 M
|
$14.20 M
|
$8.83 M
|
$7.88 M
|
| Cost And Expenses |
$51.08 M
|
$15.80 M
|
$59.73 M
|
$38.71 M
|
$19.43 M
|
$27.81 M
|
$42.64 M
|
$14.77 M
|
$9.13 M
|
$7.85 M
|
| Interest Income |
$73,000.00
|
$29,143.00
|
$115,584.00
|
$288,300.00
|
$17,442.00
|
$7,540.00
|
$88,637.00
|
$305,293.00
|
$59,161.00
|
$87,255.00
|
| Interest Expense |
$125,000.00
|
$1.09 M
|
$422,989.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$699,000.00
|
$236,842.00
|
$32,555.00
|
$29,041.00
|
$17,360.00
|
$24,640.00
|
$32,388.00
|
$23,661.00
|
$289,473.00
|
$132,653.00
|
| EBITDA |
-$13.98 M |
-$22.86 M |
-$41.45 M |
-$22.61 M |
-$33.57 M |
-$23.30 M |
-$41.38 M |
-$13.43 M |
-$8.78 M |
-$7.63 M |
| EBITDA Ratio |
-0.7
|
-1.14
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-0.73
|
-1.15
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$16.19 M
|
-$1.09 M
|
$10.80 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Income Before Tax |
-$14.80 M
|
-$24.18 M
|
-$41.91 M
|
-$22.64 M
|
-$33.59 M
|
-$23.32 M
|
-$41.41 M
|
-$13.45 M
|
-$9.07 M
|
-$7.76 M
|
| Income Before Tax Ratio |
-0.74
|
-1.21
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$56,000.00
|
$1.09 M
|
$422,989.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$14.86 M
|
-$25.28 M
|
-$42.33 M
|
-$22.64 M
|
-$33.59 M
|
-$23.32 M
|
-$41.41 M
|
-$13.45 M
|
-$9.07 M
|
-$7.76 M
|
| Net Income Ratio |
-0.74
|
-1.26
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.22 |
-0.38 |
-1.38 |
-1.36 |
-4.25 |
-4.77 |
-11.92 |
-4.29 |
-3.87 |
-3.63 |
| EPS Diluted |
-0.22 |
-0.38 |
-1.38 |
-1.36 |
-4.25 |
-4.77 |
-11.92 |
-4.29 |
-3.87 |
-3.63 |
| Weighted Average Shares Out |
$67.01 M
|
$67.01 M
|
$30.69 M
|
$16.64 M
|
$7.90 M
|
$4.89 M
|
$3.48 M
|
$3.14 M
|
$2.34 M
|
$2.14 M
|
| Weighted Average Shares Out Diluted |
$67.01 M
|
$67.01 M
|
$30.69 M
|
$16.64 M
|
$7.90 M
|
$4.89 M
|
$3.48 M
|
$3.14 M
|
$2.34 M
|
$2.14 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
